Department of Veterans Affairs Awarded a Contract to EXELAN PHARMACEUTICALS INC for $10,034.79

Q: Where is EXELAN PHARMACEUTICALS INC located?

370 W CAMINO GARDENS BLVD STE 204 BOCA RATON FLORIDA UNITED STATES

Signed on

9/16/2025, 12:00 AM

EXELAN PHARMACEUTICALS INC Government Contract #36C26125N0740

EXELAN PHARMACEUTICALS INC was awarded a contract with the United States Government for $10,034.79. The contract was awarded by the agency office 261-NETWORK CONTRACT OFFICE 21 (36C261), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Exelan Pharmaceuticals Inc, based in Boca Raton, Florida, specializing in pharmaceuticals. The contract is for Lenalidomide, funded by the Department of Veterans Affairs, with an award amount of $10,034.79. Notable spending includes a transaction with Exelan Pharmaceuticals Inc for the specified amount on September 16, 2025.

Contract Details

Contract ID36C26125N0740

Contract TypeC

Total Obligation$10,034.79

Exercised Options$10,034.79

Base Amount + Options$10,034.79

Date Signed2025-09-16

Contract DescriptionLENALIDOMIDE

Start Date2025-09-16

End Date2025-10-16

Agency Details

Awarding AgencyDepartment of Veterans Affairs

Awarding Sub AgencyDepartment of Veterans Affairs

Awarding Office261-NETWORK CONTRACT OFFICE 21 (36C261)

Funding AgencyDepartment of Veterans Affairs

Funding Sub AgencyDepartment of Veterans Affairs

Funding Office640-PALO ALTO (00640)

Recipient Details

RecipientEXELAN PHARMACEUTICALS INC

Recipient Location370 W CAMINO GARDENS BLVD STE 204 BOCA RATON FLORIDA, UNITED STATES

Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Not Designated a Small Business, Special Designations

Comments

Award Transactions

Transaction #0 | $10,034.79September 16, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $10,034.79 to EXELAN PHARMACEUTICALS INC. The payment included a Subsidy Cost of $0.00.